Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 156,000 | 196,000 | 237,000 | 438,000 | 338,000 |
| Receivables | 1,429,000 | 1,472,000 | 1,385,000 | 1,387,000 | 1,291,000 |
| Inventories | 971,000 | 955,000 | 998,000 | 981,000 | 1,022,000 |
| Income taxes - deferred | 65,000 | 75,000 | 84,000 | 78,000 | 76,000 |
| Other current assets | 405,000 | 541,000 | 477,000 | 446,000 | 437,000 |
| TOTAL | $3,026,000 | $3,239,000 | $3,181,000 | $3,330,000 | $3,164,000 |
| Non-Current Assets | |||||
| PPE Net | 1,652,000 | 1,630,000 | 1,500,000 | 1,487,000 | 1,464,000 |
| Intangibles | 12,423,000 | 12,561,000 | 12,336,000 | 12,405,000 | 12,539,000 |
| Other Non-Current Assets | 842,000 | 666,000 | 680,000 | 616,000 | 551,000 |
| TOTAL | $14,917,000 | $14,857,000 | $14,516,000 | $14,508,000 | $14,554,000 |
| Total Assets | $17,943,000 | $18,096,000 | $17,697,000 | $17,838,000 | $17,718,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,000 | 64,000 | 254,000 | 254,000 | 253,000 |
| Accounts payable and accrued liabilities | 376,000 | 447,000 | 298,000 | 284,000 | 232,000 |
| Accrued Expenses | 2,298,000 | 2,312,000 | 2,099,000 | 2,236,000 | 1,792,000 |
| Other current liabilities | 811,000 | 764,000 | 365,000 | 408,000 | 331,000 |
| TOTAL | $3,490,000 | $3,587,000 | $3,016,000 | $3,182,000 | $2,608,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,509,000 | 5,420,000 | 5,171,000 | 5,173,000 | 5,424,000 |
| Other Non-Current Liabilities | 1,872,000 | 2,338,000 | 3,002,000 | 3,239,000 | 2,934,000 |
| TOTAL | $7,400,000 | $7,776,000 | $8,199,000 | $8,436,000 | $8,653,000 |
| Total Liabilities | $10,890,000 | $11,363,000 | $11,215,000 | $11,618,000 | $11,261,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,369,402 | 1,363,489 | 1,361,677 | 1,360,743 | 1,356,867 |
| Common Shares | 16,000 | 16,000 | 19,000 | 18,000 | 16,000 |
| Retained earnings | -8,215,000 | -8,581,000 | -8,706,000 | -8,934,000 | -8,725,000 |
| Other shareholders' equity | -46,000 | 1,000 | -99,000 | -70,000 | 35,000 |
| TOTAL | $7,053,000 | $6,733,000 | $6,482,000 | $6,220,000 | $6,457,000 |
| Total Liabilities And Equity | $17,943,000 | $18,096,000 | $17,697,000 | $17,838,000 | $17,718,000 |